NCT03543618 is a NA clinical trial of Sloped in Atrophy of Edentulous Alveolar Ridge, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT03543618?

NCT03543618 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT03543618?

Interventions in NCT03543618: Sloped, Control.

What condition does NCT03543618 study?

NCT03543618 studies Atrophy of Edentulous Alveolar Ridge.

Is NCT03543618 still recruiting?

NCT03543618 is currently status unknown. Last updated 1 June 2018.

Last reviewed 2018-06-01 · How we verify

NCT03543618

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Dental Implant Placement in the Sloped Alveolar Ridge

Status unknown NA Last updated 1 June 2018

What this trial tests

NA trial testing Sloped in Atrophy of Edentulous Alveolar Ridge in 40 participants. Status unknown.

Timeline

15 March 2018

Primary endpoint
31 July 2021

31 July 2021

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	15 March 2018
Primary completion	31 July 2021
Estimated completion	31 July 2021
Sites	1 location across Taiwan

Drugs / interventions tested

Sloped
Control

Conditions studied

Atrophy of Edentulous Alveolar Ridge — all drugs for Atrophy of Edentulous Alveolar Ridge →

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 80, any sex, with Atrophy of Edentulous Alveolar Ridge. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the therapeutic effect of sloped dental implants. It can reduce the need of osteoectomy, reduce discomfort of procedures, and is easier for maintenance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03543618 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 1 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing